key: cord-0927810-fcyjytgv authors: Sugarman, Dawn E.; Busch, Alisa B.; McHugh, R. Kathryn; Bogunovic, Olivera J.; Trinh, Catherine D.; Weiss, Roger D.; Greenfield, Shelly F. title: Patients' perceptions of telehealth services for outpatient treatment of substance use disorders during the COVID‐19 pandemic date: 2021-08-17 journal: Am J Addict DOI: 10.1111/ajad.13207 sha: 8f5c7d08c8857f7dda9ed0d80a3a0d3cf5a69ac4 doc_id: 927810 cord_uid: fcyjytgv BACKGROUND AND OBJECTIVES: The rapid scale‐up of telehealth services for substance use disorders (SUDs) during the COVID‐19 pandemic presented a unique opportunity to investigate patient experiences with telehealth. This study examined patient perceptions of telehealth in an outpatient SUD treatment program offering individual therapy, group therapy, and medication management. METHODS: Two hundred and seventy adults receiving SUD outpatient treatment were eligible to complete a 23‐item online survey distributed by clinicians; 58 patients completed/partially completed the survey. Data were summarized with descriptive statistics. RESULTS: Participants were predominately male, White, and well‐educated. The majority (86.2%) were “very satisfied” or “satisfied” with the quality of telehealth care. “Very satisfied” ratings were highest for individual therapy (90%), followed by medication management (75%) and group therapy (58%). Top reasons for liking telehealth included the ability to do it from home (90%) and not needing to spend time commuting (83%). Top reasons for disliking telehealth were not connecting as well with other members in group therapy (28%) and the ability for telehealth to be interrupted at home or work (26%). DISCUSSION AND CONCLUSIONS: Telehealth visits were a satisfactory treatment modality for most respondents receiving outpatient SUD care, especially those engaging in individual therapy. Challenges remain for telehealth group therapy. SCIENTIFIC SIGNIFICANCE: This is the first study examining patients' perceptions of telehealth for outpatient SUD treatment during the COVID‐19 pandemic by treatment service type. Importantly, while many participants found telehealth more accessible than in‐person treatment, there was variability with respect to the preferred mode of treatment delivery. The expansion of telehealth care for substance use disorder (SUD) treatment has the potential to address longstanding gaps in the receipt of care; only 10.3% of people in the United States with SUDs received treatment in 2019. 1 Although the use of telehealth for SUD treatment has been growing over the past 10 years, this growth has occurred at a much slower pace than that for other mental health conditions. 2, 3 Obstacles include a more limited evidence base for its efficacy in treating SUDs 4 (compared to that for other mental health conditions), and for opioid use disorder (OUD) care specifically, the Ryan Haight Online Pharmacy Consumer Protection Act of 2008, a federal law requiring an in-person visit to prescribe controlled substances, such as buprenorphine. 5 The onset of the COVID-19 pandemic in the United States brought about a tremendous growth in the use of telehealth across a range of healthcare providers and medical conditions; starting with the federally declared state of emergency in March 2020, in-person visits decreased dramatically. [6] [7] [8] Telehealth enabled providers to maintain patient care while minimizing in-person visits in an effort to slow the spread of the coronavirus. The rapid uptake of telehealth was further aided by the relaxation of federal, state, and health insurance regulations and payment practices that were more restrictive prior to the pandemic. 9, 10 In particular, an emergency exemption was granted to the Ryan Haight Act, which allowed providers to prescribe controlled substances via telehealth without an in-person visit. 11 There is a robust evidence base that demonstrates that telehealth is at least as effective as in-person care for several behavioral health conditions-particularly for depression and anxiety disorders. [12] [13] [14] [15] [16] There is also evidence that patients with behavioral health conditions are generally satisfied with telehealth, both in terms of the patient clinical experience and benefits of improved access to and convenience of care. 17 Prior studies of patient perceptions of telehealth, specifically for SUD care, have shown high levels of patient satisfaction with telehealth treatment that are comparable with in-person treatment. 4, 18, 19 However, the existing literature examining SUD care via telehealth is more limited than for other behavioral health conditions, and the quality of the evidence of these studies is variable. 4 Participants were included in this study if they were 18 years or older and currently engaged in outpatient telehealth treatment in the ADATP. All study procedures were approved by the Mass General Brigham Institutional Review Board (IRB). The IRB waived the requirement for written informed consent for this study. Participants were informed about the purpose, content, and risks and benefits of the study via a study fact sheet, and eligible subjects indicated their agreement to participate in the study by clicking on a checkbox next to the statement "I agree to participate in this research." Clinicians in the ADATP sent a link to the study fact sheet and survey to their current patients enrolled in outpatient treatment. Prior to reviewing the study fact sheet, participants completed prescreening questions to confirm that they were 18 years or older and that they had not previously completed the survey. The survey was active from June 8, 2020 to July 12, 2020. During that time period, there were 270 unique patients in the ADATP. All clinicians were encouraged to invite their patients to complete the survey. We were unable to collect data on the precise numbers of patients who were invited by their clinicians to complete the survey. Participants did not receive any remuneration for participating in the study. Seventy-six patients completed prescreening questions, and 65 patients consented to participate in the study. Seven participants did not complete any questions after consenting; therefore, data were analyzed for the 58 participants who completed or partially completed the survey. Descriptive statistics (frequencies, means, and standard deviations) were used to summarize the survey data. Pairwise correlation was used to examine the association between satisfaction with telehealth and length of time in treatment. Participants completed the Telehealth Patient Survey, a 23-item selfreport survey focused on measuring participants' experiences with telehealth in the ADATP. Our focus was on understanding patient experiences with video visits, therefore in the survey instructions participants were informed, "We would like to better understand your experience using Zoom for telehealth." Questions were derived from the McLean Anxiety Mastery Program Telehealth Satisfaction Questionnaire 20 and assessed the frequency and type of services received via telehealth, as well as satisfaction with telehealth for each treatment service, preference for service delivery type (e.g., telehealth, in-person, a mix of both, no preference), factors they liked and disliked about telehealth, and technical issues accessing telehealth. In addition, participants were asked questions about their demographic characteristics, such as age, gender, and education, and questions about their current substance use. Demographic and substance use characteristics are summarized in Table 1 . The sample was primarily male (66%), White (92%), and welleducated (45% completed post-graduate education). Alcohol (59%) was most commonly identified as the substance that had caused participants the most difficulties lately. Most participants (78%) were engaged in group therapy; just over half (52%) were receiving individual therapy and 41% were receiving medication management. Few participants (n = 5, 8.6%) reported that they had ever received telehealth treatment services prior to COVID-19. Very few participants (n = 2, 3.5%) reported having difficulty logging into the telehealth platform; 95% were "satisfied" or "very satisfied" with the sound quality and 86% were "satisfied" or "very satisfied" with the video quality of the telehealth program. Five participants (8.6%) clicked "not applicable" in response to the video quality question, suggesting that these participants were engaged in audio-only telehealth visits. Table 2 provides descriptive data on telehealth receipt and satisfaction. The majority of participants (86.2%) reported that they were "very satisfied" or "satisfied" with the quality of telehealth care. In addition, 82% of the sample indicated telehealth visits met their needs "equally well" or "better" than in-person visits. Satisfaction was not significantly correlated with length of time in telehealth treatment (r = .108, n = 58, p = .421). Of participants who received these services, a majority reported feeling "very satisfied" with individual therapy (90%) and individual medication management (75%). In contrast, only 58% of participants who received group therapy were "very satisfied" with receiving this service via telehealth ( Figure 1 ). The preferred mode of treatment delivery was varied ( Figure 2 with individual therapy and medication management, but less than 60% of people who received group therapy were very satisfied. Although group therapy delivered via telehealth has been shown to be feasible and associated with treatment outcomes similar to in-person group treatment, there is some evidence of decreased therapeutic alliance for group telehealth treatment compared to in-person treatment. 21, 22 Similarly, in this study, over a quarter of participants indicated that they did not connect as well with other group members in group telehealth therapy, and this was the most commonly reported telehealth factor disliked by participants. In this study, satisfaction with telehealth overall was quite strong, with over 85% reporting that they were satisfied or very Therefore, another way to consider these results is that the majority of participants preferred care that included telehealth-either as their sole mode of treatment or as some part of their care combined with in-person treatment. When the mode of treatment delivery is not dictated by COVID-19 safety guidelines, it will be important to understand how best to offer telehealth to patients (hybrid or sole mode of treatment), and which individual treatment characteristics to consider. In addition, while we did not find that satisfaction scores were associated with the duration of telehealth services, it is notable that the majority of participants in our sample (83%) were engaged in SUD treatment in the ADATP prior to the transition to telehealth. Therefore, it is possible that these patients were already established and connected to their treatment provider(s), which may have facilitated the transition to telehealth. There is some evidence of reduced group cohesion and patient-reported therapeutic alliance with group telehealth for posttraumatic stress disorder. 21 It is possible that therapeutic alliance may vary not only by individual differences in the ability to establish an alliance 23 but that those with already established providers may find therapeutic alliance more durable with a transition to telehealth than those with new providers. One of the key potentials of telehealth is in increasing access to care for individuals who have difficulty accessing in-person treatment services. Few participants in this sample were new to treatment (n = 10); therefore, we were unable to examine whether preferences and satisfaction for telehealth differed for those established in treatment compared with patients new to treatment. For example, telehealth might be more likely to be rated as the preferred mode of treatment delivery in participants who have little to no access to in-person treatment, compared with those who have equal access to both telehealth and in-person care. Insurance coverage of telehealth will also likely influence patient preferences for its use. Pre-pandemic, insurance coverage for telehealth was more lim- There are several limitations to this study. First, this is a singleclinic study, and the sample size is small and not diverse with respect to race and ethnicity. Therefore these findings may not generalize to other clinics and populations. In addition, we recruited participants for this study who were already engaged in telehealth treatment, and thus, by nature, had already overcome initial barriers to access. Second, likes and dislikes were measured as a binary response, rather than a Likert scale; therefore, we were unable to assess the degree to which participants liked or disliked each of the items. In addition, although some of the items implied comparison with in-person treatment (e.g., I don't connect as well with other group members in group therapy), we did not assess the likes/dislikes of in-person treatment to make direct comparisons. Third, we do not know how representative the sample is of the total ADATP outpatient treatment population, as we were unable to track the number of patients invited to take the survey and therefore do not know the proportion of patients responding. Selection bias may also have occurred insofar as patients who were more satisfied with treatment may have been more likely to respond to their clinician's invitation to complete the survey. In spite of these limitations, to our knowledge, this is the first study examining patients' perceptions of telehealth for outpatient SUD treatment during the COVID-19 pandemic by treatment service type. Importantly, while there was high overall satisfaction with telehealth services and many participants found telehealth more accessible than in-person treatment, there was variability with respect to the preferred mode of treatment delivery. Although almost 40% of the sample reported that there was nothing that they dislike about telehealth, some participants also identified important potential barriers, such as difficulty forming connections with other group members, difficulties discussing sensitive topics, lower feelings of safety through telehealth, and difficulty with internet connectivity. With the goal of using telehealth to potentially increase access to SUD outpatient treatment services, it will be important for new research to examine the relationship among patient preferences for telehealth versus in-person treatment services, treatment access, engagement, retention, and SUD treatment outcomes. Substance Abuse and Mental Health Services Administration. Key Substance Use and Mental Health Indicators in the United States: Results from the 2019 National Survey on Drug Use and Health How is telemedicine being used in opioid and other substance use disorder treatment? Adoption of telemedicine services by substance abuse treatment facilities in the U.S Telemedicine-delivered treatment interventions for substance use disorders: a systematic review Implementation of the Ryan Haight Online Pharmacy Consumer Protection Act of 2008. Interim final rule with request for comments Office of the Assistant Secretary for Planning and Evaluation, Department of Health and Human Services The impact of the COVID-19 pandemic on outpatient visits: a rebound emerges Treatment of opioid use disorder among commercially insured patients in the context of the COVID-19 pandemic Federation of State Medical Boards. U.S. states and territories modifying requirements for telehealth in response to COVID-19 COVID-19 related state actions COVID-19 telehealth coverage policies Videoconferencing in psychiatry, a meta-analysis of assessment and treatment Review of key telepyschiatry outcomes Synchronous telehealth technologies in psycotherapy for depresssion: a metaanalysis A systematic review of videoconferencedelivered psychological treatment for anxiety disorders Efficacy of telehealth treatments for posttraumatic stress-related symptoms: a meta-analysis Barriers to use of telepsychiatry: clinicians as gatekeepers A randomized trial of Web-based videoconferencing for substance abuse counseling Patient satisfaction with videoconferencing-based treatment for alcohol use disorders McLean Anxiety Mastery Program Telehealth Satisfaction Questionnaire (MAMP-TSQ) Evidence for telehealth group-based treatment: a systematic review Patient perceptions of telemental health: systematic review of direct comparisons to in-person psychotherapeutic treatments The role of therapeutic alliance in substance use disorder treatment for young adults Is telemedicine the answer to rural expansion of medication treatment for opioid use disorder? Early experiences in the feasibility study phase of a National Drug Abuse Treatment Clinical Trials Network Trial Treatment of opioid use disorder during COVID-19: experiences of clinicians transitioning to telemedicine Clinicians' perceptions of rapid scale-up of telehealth services in outpatient mental health treatment Staying safe during COVID-19: How a pandemic can escalate risk for intimate partner violence and what can be done to provide individuals with resources and support World Health Organization. COVID-19 and violence against women: What the health sector/system can do Digital divide persists even as lower-income Americans make gains in tech adoption Smartphones Help Blacks, Hispanics Bridge Some-But Not All-Digital Gaps With Whites. Washington DC: Pew Research Center Digital health equity and COVID-19: the innovation curve cannot reinforce the social gradient of health Patients' perceptions of telehealth services for outpatient treatment of substance use disorders during the COVID-19 pandemic The authors would like to thank Elizabeth Fox for supplying outpatient encounter data and Angela Perrault for providing data on unique patient visits. The authors would like to acknowledge the support from NIDA K23DA050780 (DES) and R01DA048533 (ABB and SFG), and the Charles Engelhard Foundation. The authors declare that there are no conflict of interests.